
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
The positive outlook on American Healthcare REIT Inc. is underpinned by anticipated growth in acquisition activity, with potential additional investments projected at $600 million in 2026, enhancing their diversified portfolio. The company has experienced robust same-store cash Net Operating Income (NOI) growth, with forecasts suggesting a two-year compound annual growth rate (CAGR) of 11.8% for Trilogy and 15.5% for SHOP, reflecting improving operational efficiencies and a favorable market environment. Furthermore, the strengthened cost of capital positions American Healthcare REIT to pursue more aggressive and accretive capital deployment, potentially leading to superior external growth outcomes.
Bears say
American Healthcare REIT Inc faces several challenges that contribute to a negative outlook on its stock, primarily stemming from tenant risks and macroeconomic factors. A significant portion of the company's revenues is derived from its Integrated Senior Health Campuses segment, which includes skilled nursing facilities; thus, any deterioration in the financial health of tenants, particularly those reliant on Medicaid, could adversely impact earnings expectations. Additionally, the company is exposed to various operational risks, including regulatory changes affecting skilled nursing facilities, rising construction costs, and capital market volatility, all of which could hinder its ability to achieve organic net operating income growth and ultimately affect overall stock performance.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares